← Back to catalogue
Research draft

botulism

vr.tr.botulism · INF.KNW

Enable an agent to recognise a possible botulism episode, record its evidence and progression, and support timely clinical and public-health escalation.

Thing Registry Information and virtual systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

recalled by Codex without web access - no source was read

Researched by: Codex

Purpose and description

Enable an agent to recognise a possible botulism episode, record its evidence and progression, and support timely clinical and public-health escalation.

Botulism is a potentially fatal neuroparalytic disease caused by botulinum neurotoxins, produced chiefly by Clostridium botulinum, which inhibit acetylcholine release at peripheral cholinergic nerve terminals and typically cause descending flaccid paralysis.

It can be Flag a compatible presentation for urgent clinician assessment and botulism consultation.; Build a timed exposure and symptom history while preserving competing explanations.; Prepare a diagnostic-evidence summary that distinguishes pending tests from negative results.; Track clinician-directed antitoxin access, respiratory support and form-specific management.; Link potentially shared exposures for authorized public-health investigation.; Track recovery and unresolved neurological or functional limitations..

Distinguishing features

A compatible neuroparalytic syndrome distinguishes suspected botulism from gastrointestinal illness alone; gastrointestinal symptoms do not establish the diagnosis.

Cranial nerve involvement followed by symmetric descending flaccid weakness supports recognition; assess sensory findings and alternative diagnoses rather than treating the pattern as a standalone diagnostic test. [CDC clinical overview](https://www.cdc.gov/botulism/hcp/clinical-overview/index.html)

Distinguish disease in a patient from toxin or bacterial detection in an environmental or food sample.

Infant botulism involves intestinal colonization and toxin production, so an infant's exposure history must distinguish swallowed spores from preformed toxin. [CDC infant overview](https://www.cdc.gov/botulism/hcp/clinical-overview/infant-botulism.html)

Following botulinum toxin injection, distinguish localized effects from findings supporting systemic botulism. [CDC injection-related guidance](https://www.cdc.gov/botulism/hcp/diy-botox/index.html)

Scope

+ Botulism disease identity and boundaries with other causes of paralysis

+ Exposure route and clinical form, with uncertainty preserved

+ Neurological presentation, respiratory risk and progression

+ Diagnostic evidence and separate clinical and surveillance classifications

+ Treatment decisions, recovery and links to source investigations

- Taxonomy and cultivation of toxin-producing bacteria

- Botulinum toxin manufacture, purification and molecular engineering

- Routine cosmetic or therapeutic injection practice

- General food-processing specifications and recall administration

- Full models of differential diagnoses such as myasthenia gravis

- Animal botulism and veterinary management

Characteristics

Clinical form
Foodborne; wound; infant intestinal; adult intestinal colonization; iatrogenic; other documented route; undetermined Organizes exposure assessment, specialist consultation and source-control questions without forcing an unsupported assignment.
Clinical assessment
Suspected; clinically supported; alternative diagnosis favored; unresolved, with assessor and timestamp Keeps clinical urgency separate from laboratory completion.
Surveillance classification
Label under a named jurisdictional case definition and version; unclassified Prevents surveillance eligibility from becoming a diagnostic gate.
Neurological distribution
Cranial, bulbar, limb and autonomic findings; symmetry; direction of progression; unknown Makes the pattern and its changes assessable.
Respiratory assessment
Clinician-selected measures with units, method, time and reliability; support status recorded separately Supports interpretation of trends instead of relying on one undocumented severity label.
Episode timing
Exposure, symptom onset, consultation and treatment timestamps; intervals in hours or days; uncertainty ranges Supports exposure attribution and review of treatment delays.
Diagnostic evidence
Links to patient specimens, implicated-source specimens, assay reports and expert interpretations Preserves the distinction between evidence of illness and evidence about its source.
Functional recovery
Breathing, swallowing, feeding, mobility and communication status relative to baseline Makes continuing care needs visible after acute treatment.

Also called

iatrogenic botulismavian botulismfoodborne botulismtoxin-mediated infectious botulisminhalational botulism

Where this came from

wikidata · CC0 1.0

Also registered as vr.tr.botulism

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 17 findings · 28 questions.

Disease identity and form Establish what counts as botulism and which clinical form is being considered.

The disease, its causative toxin and its bacterial producers require separate identities.

Toxin-mediated disease

Define the patient illness and its causal attribution.

Illness versus hazard

Record whether the assertion concerns patient disease, exposure alone or detection in a possible source.

  1. What evidence supports botulinum neurotoxin-mediated illness in this patient? definition
  2. Does the available evidence establish illness, exposure, or only contamination of a possible source? boundary

Form assignment

Relate the illness to a documented or hypothesized route.

Route and toxin origin

Separate preformed toxin exposure from toxin production within the patient, retaining an undetermined category.

  1. Which clinical form is supported, and what evidence distinguishes it from the other forms? boundary
  2. Who assigned the form, using which history, investigation or laboratory evidence? provenance
Presentation and progression Represent the neurological pattern and changes that affect urgency.

Recognition depends on the distribution and evolution of impairment, including age-dependent presentation.

Neurological pattern

Organize serial cranial, bulbar and limb examinations.

Pattern and age context

Record observed findings, absent findings and examination limitations; infant observations include feeding, cry and tone.

  1. Which cranial, swallowing and limb findings occurred first, and how have they progressed? measurement
  2. For an infant, what changes in feeding, cry, stooling and muscle tone were observed relative to baseline? measurement

Breathing and swallowing

Track threats to ventilation and airway protection.

Respiratory risk trajectory

Preserve serial respiratory and bulbar assessments with the responsible clinician's escalation decision.

  1. What do serial breathing, cough, secretion-management and swallowing assessments show? measurement
  2. What findings require immediate escalation under the treating team's applicable protocol? action
Diagnostic evidence Make diagnostic confidence and competing explanations inspectable.

Urgent clinical decisions and formal confirmation operate on different timelines.

Clinical differentiation

Compare botulism with plausible causes of weakness or cranial neuropathy.

Competing explanations

Record positive and conflicting evidence for botulism, Guillain-Barré variants, myasthenia gravis and relevant central lesions.

  1. Which examination or investigation findings favor each competing explanation? boundary
  2. Which atypical findings require specialist reassessment without prematurely excluding botulism? action

Confirmation and classification

Connect laboratory reports to clinical interpretation and surveillance rules.

Specimen meaning

Record specimen origin, collection timing, assay and interpretation; keep surveillance classification distinct from diagnosis. [CDC case-definition boundary](https://ndc.services.cdc.gov/case-definitions/botulism-2011/)

  1. Which patient or source specimen was tested, by which laboratory and method, and when relative to onset and treatment? provenance
  2. How does the specialist interpret a positive, negative or inconclusive result in this episode? boundary
  3. Which named surveillance definition and version supports the recorded classification? provenance
Urgent care and recovery Track time-sensitive consultation, treatment and continuing disability.

The model must distinguish limiting further toxin injury from recovery of existing impairment.

Consultation and antitoxin

Represent expert assessment and access to the appropriate treatment pathway.

Treatment without confirmation delay

When expert clinical consultation supports botulism, treatment should begin promptly without waiting for laboratory confirmation. [CDC clinical overview](https://www.cdc.gov/botulism/hcp/clinical-overview/index.html)

  1. When was botulism suspected, when was expert consultation reached, and what decision followed? provenance
  2. Which infant or non-infant treatment pathway applies, and what access barriers remain? action

Support and functional return

Track supportive care, form-specific interventions and recovery.

Ongoing impairment

Antitoxin limits further injury but does not reverse established paralysis; record respiratory support, wound management where indicated and rehabilitation needs. [CDC treatment](https://www.cdc.gov/botulism/treatment/index.html)

  1. Which respiratory, nutritional, communication and mobility supports are currently required? measurement
  2. What form-specific interventions and rehabilitation milestones has the treating team documented? action
Exposure and public health Connect individual illness to possible sources and jurisdiction-specific response.

A clinical episode may reveal an exposure affecting additional people, while source attribution can remain uncertain.

Source attribution

Keep candidate exposures and their evidential strength separate.

Exposure link strength

Record relevant foods, wounds, injection histories or intestinal exposure hypotheses without treating temporal association as proof.

  1. Which candidate exposures fit the episode timeline and proposed clinical form? provenance
  2. What corroborates each link: patient history, shared exposure, source testing or an investigator's assessment? provenance

Notification and shared exposure

Identify the responsible authority and preserve investigation links.

Authorized response

Record applicable notification requirements, authority contact and source-control decisions rather than assuming one jurisdiction's rules apply everywhere.

  1. Which jurisdiction and current reporting rule apply, and has the responsible authority received the report? action
  2. Are other illnesses or exposed people linked, and what investigation or source-control action has the authority directed? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  • This describes the disease, not a discipline or field of knowledge; the supplied INF.KNW domain assignment warrants review.
  • The content is recalled knowledge without source verification; jurisdiction-specific coding and regulation require checking.
  • Inhalational botulism is a recognized but exceptionally rare exposure category; the listed forms are not equally common.
  1. Which of these check these first hold for the sense of botulism this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  • Foodborne botulism
  • Infant botulism
  • Wound botulism
  • Adult intestinal colonization botulism
  • Iatrogenic botulism
  • Inhalational botulism
  1. Which of these kinds and varieties hold for the sense of botulism this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  • ICD-10 - A05.1 - Botulism is classified within bacterial foodborne intoxications; coding of particular forms should be checked against the applicable national modification.
  1. Which of these identifiers and schemes hold for the sense of botulism this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  • Clinical recognition and differential diagnosis of acute flaccid paralysis
  • Public-health surveillance and investigation of foodborne outbreaks
  • Food-preservation safety assessment and control of botulinum toxin formation
  • Safety monitoring of therapeutic and cosmetic botulinum toxin administration
  1. Which of these real-world use hold for the sense of botulism this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  • Respiratory muscle paralysis can cause fatal respiratory failure.
  • Impaired swallowing can cause aspiration.
  • Improperly preserved foods can permit toxin formation without reliably detectable changes in appearance, smell or taste.
  • Intestinal colonization by toxin-producing organisms can cause infant botulism; honey is a recognized avoidable exposure source.
  • Delayed recognition can occur because early cranial nerve symptoms resemble other neurological disorders.
  1. Which of these failure modes and hazards hold for the sense of botulism this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  • Foodborne exposure patterns vary with local preservation methods and consumption of home-canned, fermented or preserved foods.
  • Reporting requirements, laboratory capacity and access to antitoxin vary between jurisdictions.
  1. Which of these regional variation hold for the sense of botulism this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  • Clostridium botulinum - The bacterium is a principal producer of the toxin; botulism is the disease caused by toxin activity.
  • Botulinum toxin - The toxin is the causative substance and can also be used medicinally; botulism is the resulting clinical disease.
  • Tetanus - Tetanus typically causes rigidity and painful spasms, whereas botulism typically causes flaccid paralysis.
  • Myasthenia gravis - Myasthenia gravis usually involves autoimmune impairment of postsynaptic neuromuscular transmission; botulism impairs presynaptic acetylcholine release through toxin action.
  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of botulism this model covers, and on what evidence? provenance

What the second pass must settle

  • Does an existing Vercy world model already own botulism or an encompassing disease concept that this registry entry should reference?
  • Should INF / INF.KNW remain solely the registry placement, or does the catalogue require a separate relation identifying the disease sense?
  • Which jurisdiction-specific case definitions, reporting pathways and antitoxin-access arrangements should the first researched publication support?
  • Which specialist criteria should distinguish systemic iatrogenic botulism from localized injection effects and other adverse reactions?
  • Which age-appropriate respiratory and functional measures should be standardized, and how should unreliable or unobtainable measurements be represented?